Search

Search Constraints

You searched for: Author/Creator Murata, Kenya

Search Results

2. Efficacy and Safety of Bimagrumab in Sporadic Inclusion Body Myositis: Long-term Extension of RESILIENT. (23rd March 2021)

5. Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial. Issue 9 (September 2019)